She has no idea. It's blind.
She's speaking with the abundance of caution of a scientist. She really only has any idea of her own patients, some of whom have done extremely well, and even then, we're talking about the ones outside of the trial or from the earlier phases of the trial, when it was not blind and there was no placebo. But she can't extrapolate and she's not speaking as a corporate presenter, looking at all the data. She is not a promoter, no matter what people think she should or should not be doing.
You're exactly right Doc.
The notions that people bandy about are always entertaining and give fodder to the shorts, unfortunately. But taking her comments to the extent that some do, and extrapolating as far as people do from one conversation she has to the other, is often just bad due diligence. She's clearly a very cautious speaker, and I don't fault her for that fact. It's what makes her a good scientist.
Market Data 
Markets 
AI
